Detection and half-life of bromobenzene-3,4-oxide in blood.
暂无分享,去创建一个
T. Monks | S. Lau | J. Gillette | K. Greene
[1] T. Monks,et al. Activation and detoxification of bromobenzene in extrahepatic tissues. , 1984, Life sciences.
[2] T. Monks,et al. Intra- and extra-cellular formation of metabolites from chemically reactive species. , 1984, Biochemical Society transactions.
[3] T. Monks,et al. Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene. , 1984, The Journal of pharmacology and experimental therapeutics.
[4] J R Gillette,et al. Stereoselective formation of bromobenzene glutathione conjugates. , 1982, Chemico-biological interactions.
[5] T. Monks,et al. Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. , 1982, Life sciences.
[6] S. Lau,et al. Bromobenzene epoxidation leading to binding on macromolecular protein sites. , 1981, The Journal of pharmacology and experimental therapeutics.
[7] J R Gillette,et al. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. , 1973, The Journal of pharmacology and experimental therapeutics.
[8] G. Krishna,et al. Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbons. , 1973, Experimental and molecular pathology.
[9] M. Eichelbaum,et al. 3-Methylcholanthrene blocks hepatic necrosis induced by administration of bromobenzene or carbon tetrachloride. , 1971, Experimental and molecular pathology.
[10] D. Jollow,et al. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. , 1974, Pharmacology.
[11] B B Brodie,et al. Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[12] B. Brodie,et al. Bromobenzene metabolism and hepatic necrosis. , 1971, Pharmacology.